Projekt

A Randomized multicenter phase III trial comparing enzalutamide vs. a combination of Ra223 and enzalutamide in asymptomatic or mildly symptomatic castration resistant prostate cancer patients metastatic to bone. PEACE III

Laufend - Rekrutierung – beendet · 2015 bis 2030

Rothermundt Christian, Demmer-Steingruber Ruth, Quinter Janine